$145.68

Quote Date: Nov 12, 7:31PM EST

Data delayed 15 minutes Currency in USD

Company Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

  TTM2017201620152014
Revenue $81,382$76,450$71,890$70,074--
Cost of Revenue Expense $27,373$25,354$21,685$21,536--
Gross Profit $54,009$51,096$50,205$48,538--
Selling, General & Administrative Expense $22,574$21,420$19,945$21,203--
Operating Income $18,715$18,714$21,136$18,065--
Interest Expense $1,029$934$726$552--
Pretax Income $17,437$17,673$19,803$19,196--
Provision Tax Income $15,895$16,373$3,428$3,787--
Net Income $1,542$1,300$16,375$15,409--
EPS Fully Diluted $0$0$6$5$6
EBITDA $25,529$24,249$24,283$23,494--
  TTM2017201620152014
Cash & Cash Equivalents $16,056$17,824$18,972$13,732--
Short Term Receivables $14,048$13,490$11,699$10,734--
Inventories $8,678$8,765$8,144$8,053--
Total Cash $0$0$0$0--
Current Assets $47,194$43,088$65,032$60,210--
Total Assets $155,703$157,303$141,208$133,411--
Short Term Debt $1,773$3,906$4,684$7,004--
Accounts Payable $7,000$7,310$6,918$6,668--
Total Current Liabilities $27,437$30,537$26,287$27,747--
Long Term Debt $29,480$30,675$22,442$12,857--
Deferred Tax Liabilities $7,711$8,368$2,910$2,562--
Total Liabilities $91,077$97,143$70,790$62,261--
Total Stock Holders Equity $64,626$60,160$70,418$71,150--
Total Equity $64,626$60,160$70,418$71,150--
  TTM2017201620152014
Operating Cash Flow $0$0$0$0--
Investing Cash Flow -$5,900-$14,868-$4,761-$7,735--
Dividends Paid $9,339$8,943$8,621$8,173--
Financing Cash Flow -$15,658-$7,673-$8,551-$10,846--
Free Cash Flow $18,305$17,543$15,418$15,713--

Unique Data Points

  TTM2017201620152014
Customer Revenue $81,382$76,450$71,890$70,074$74,331
Sales to Customers Revenue $81,382$76,450$71,890$70,074$74,331
Selling, Marketing & Administrative Expense $22,574$21,420$19,945$21,203$21,954
Shares Outstanding $2,732$2,685$2,765$2,803$2,845
Asia-Pacific & Africa Customer Revenue $14,731$13,420$12,575$12,347$13,442
Europe Customer Revenue $18,751$17,126$15,925$15,995$18,947
International Advanced Revenue $2,324$2,136$1,993$1,845--
International Babycare Revenue $1,446$1,467$1,400$1,629$1,832
International Beauty Care Revenue $1,994$1,865$1,762$461--
International Cardiovascular Revenue $282$1,025$901$1,105$1,346
International CARDIOVASCULAR / METABOLISM Revenue $1,562$1,518$1,541$1,659$1,977
International Concerta & Methylphenidate Revenue $425$407$395$387$447
International Consumer Revenue $8,196$8,037$7,887$8,285$9,400
International CONTACT LENSES / OTHER Revenue $2,048$1,914$1,715----
International Customer Revenue $39,658$36,587$34,079$34,387$39,549
International Darzalex Revenue $955$771$200----
International Diabetes Care Revenue $898$1,003$1,050$1,095$1,278
International Diagnostics Revenue $0$1$66$86$506
International Edurant Revenue $759$656$521$369$341
International General Revenue $2,812$2,735$2,693$2,780--
International Hips Revenue $581$567$563$408--
International Imbruvica Revenue $1,404$1,052$638$314--
International Immunology Revenue $3,920$3,373$3,122$2,760$3,082
International Infectious Diseases Revenue $1,958$1,796$1,747$2,121$2,487
International Invega Sustenna, Xeplion & Trinza Revenue $1,116$979$871$745$763
International INVOKANA / INVOKAMET Revenue $176$167$134$70$14
International Knees Revenue $589$575$581$430--
International Medical Devices Revenue $14,363$13,768$12,853$13,005$15,268
International Neuroscience Revenue $3,488$3,356$3,457$3,409$4,035
International Oncology Revenue $5,235$4,160$3,472$3,148$3,300
International OPSUMIT Revenue $504$253------
International Oral Care Revenue $921$915$920$951$1,047
International Orthopaedics Revenue $3,650$3,777$3,813$3,882$4,478
International OTHER / CARDIOVASCULAR / METABOLISM Revenue $1,074$1,054$1,069$1,213$1,445
International Other Immunology Revenue $68$23$25$39$66
International OTHER INFECTIOUS DISEASES Revenue $401$428$513$558$881
International Other Neuroscience Revenue $1,516$1,614$1,828$1,521$1,782
International Other Oncology Revenue $360$359$390$340$416
International OTHER PULMONARY HYPERTENSION Revenue $65$59------
International Over the Counter Revenue $2,526$2,410$2,357$2,408$2,749
International Pharmaceutical Customer Revenue $17,099$14,782$13,339$13,097$14,881
International PREZISTA / PREZCOBIX / REZOLSTA Revenue $798$712$708$746$901
International PROCRIT / EPREX Revenue $312$297$338$376$523
International Pulmonary Hypertension Revenue $936$579------
International Remicade Revenue $1,199$1,227$1,342$1,326$1,635
International Risperdal Consta Revenue $431$445$512$561$763
International Simponi/Simponi Aria Revenue $1,060$879$816$598$643
International Specialty Revenue $629$603$584$601--
International Spine & Other Revenue $1,379$1,595$1,645$1,251--
International Stelara Revenue $1,593$1,244$969$797$738
International Surgery Revenue $5,765$5,474$5,270$5,226--
International Surgical Revenue $707$574------
International TRACLEER Revenue $305$242------
International Trauma Revenue $1,101$1,040$1,024$774--
International UPTRAVI Revenue $62$25------
International Velcade Revenue $1,135$1,114$1,224$1,333$1,618
International Vision Care Revenue $2,755$2,488$1,753$1,611--
International Womens Health Revenue $1,041$1,038$1,038$1,174$1,232
International Wound Care Revenue $268$342$348$420$596
International Zytiga Revenue $1,645$1,277$1,171$1,161$1,266
US Advanced Revenue $1,646$1,620$1,524$1,430--
US Baby Care Revenue $429$449$442$444$407
US Beauty Care Revenue $2,387$2,335$2,135$442--
US Cardiovascular Revenue $286$1,071$948$931$862
US CARDIOVASCULAR / METABOLISM Revenue $4,486$4,725$4,855$4,759$3,600
US Concerta & Methylphenidate Revenue $291$384$468$434$152
US Consumer Revenue $5,661$5,565$5,420$5,222$5,096
US CONTACT LENSES / OTHER Revenue $1,238$1,122$1,050----
US Customer Revenue $41,724$39,863$37,811$35,687$34,782
US Darzalex Revenue $1,121$884$151----
US Diabetes Care Revenue $501$612$739$833$864
US Diagnostics Revenue $0$0$0$0$456
US Edurant Revenue $56$58$52$41$25
US General Revenue $1,734$1,728$1,669$1,702--
US Hips Revenue $836$827$798$591--
US Imbruvica Revenue $1,030$841$613$375--
US Immunology Revenue $8,944$8,871$8,846$7,642$7,111
US INFECTIOUS DISEASES Revenue $1,344$1,358$1,461$1,535$3,112
US Invega Sustenna, Xeplion & Trinza Revenue $1,742$1,590$1,343$1,085$825
US INVOKANA / INVOKAMET Revenue $744$944$1,273$1,238$555
US Knees Revenue $918$948$943$690--
US Medical Devices Revenue $12,937$12,824$12,266$12,132$12,254
US Neuroscience Revenue $2,613$2,630$2,628$2,850$2,452
US Oncology Revenue $4,159$3,098$2,335$1,587$1,157
US OPSUMIT Revenue $657$320------
US Oral Care Revenue $628$616$648$629$600
US Orthopaedics Revenue $5,312$5,481$5,521$5,380$5,197
us OTHER / CARDIOVASCULAR / METABOLISM Revenue $476$606$527$961$987
US Other Immunology Revenue $357$62------
US OTHER INFECTIOUS DISEASES Revenue $156$191$261$257$215
US Other Neuroscience Revenue $255$296$390$583$688
US Other Oncology Revenue $186$145$381$82$186
US OTHER PULMONARY HYPERTENSION Revenue $89$73------
US Over the Counter Revenue $1,765$1,716$1,633$1,540$1,357
US Pharmaceutical Customer Revenue $23,126$21,474$20,125$18,693$17,432
US PREZISTA / PREZCOBIX / REZOLSTA Revenue $1,132$1,109$1,143$1,064$930
US PROCRIT / EPREX Revenue $687$675$767$692$715
US Pulmonary Hypertension Revenue $1,580$792------
US Remicade Revenue $3,894$4,525$4,842$4,453$4,155
US Risperdal Consta Revenue $325$360$381$409$427
US Simponi/Simponi Aria Revenue $1,032$954$959$730$544
US Specialty Revenue $727$737$833$859--
US Spine & Other Revenue $1,965$2,130$2,235$1,692--
US Stelara Revenue $3,200$2,767$2,263$1,677$1,334
US Surgery Revenue $4,107$4,085$4,026$3,911--
US Surgical Revenue $546$453------
US TRACLEER Revenue $284$161------
US Trauma Revenue $1,593$1,576$1,545$1,098--
US UPTRAVI Revenue $550$238------
US Vision Care Revenue $1,784$1,575$1,032$997--
US Womens Health Revenue $13$12$19$26$49
US Wound Care Revenue $439$437$522$723$848
US XARELTO Revenue $2,579$2,500$2,288$1,868$1,522
US Zytiga Revenue $1,822$1,228$1,089$1,070$971
US Exports Remicade Revenue $461$563$838$782$1,078
Western Hemisphere Customer Revenue $6,176$6,041$5,734$6,045$7,160
Worldwide Advanced Revenue $3,970$3,756$3,517$3,275--
Worldwide Babycare Revenue $1,875$1,916$2,001$2,044$2,239
Worldwide Beauty Care Revenue $4,381$4,200$3,897$903--
Worldwide Cardiovascular Revenue $568$2,096$1,849$2,036$2,208
Worldwide Cardiovascular / Metabolism Revenue $6,048$6,243$6,396$6,418$5,577
Worldwide Concerta & Methylphenidate Revenue $716$791$863$821$599
Worldwide Consumer Revenue $13,857$13,602$13,307$13,507$14,496
Worldwide Contact Lenses / Other Revenue $3,286$3,036$2,765----
Worldwide Darzalex Revenue $1,812$1,242$200----
Worldwide Diabetes Care Revenue $1,399$1,615$1,789$1,928$2,142
Worldwide Diagnostics Revenue $0$1$66$86$962
Worldwide Edurant Revenue $815$714$573$410$365
Worldwide General Revenue $3,377$4,463$4,362$4,482--
Worldwide Hips Revenue $1,417$1,394$1,361$999--
Worldwide Imbruvica Revenue $2,434$1,893$1,251$689--
Worldwide Immunology Revenue $12,864$12,244$11,968$10,402$10,193
Worldwide Infectous Diseases Revenue $3,302$3,154$3,208$3,656$5,599
Worldwide Invega Sustenna, Xeplion & Trinza Revenue $2,858$2,569$2,214$1,830$1,588
Worldwide INVOKANA / INVOKAMET Revenue $920$1,111$1,407$1,308$569
Worldwide Knees Revenue $1,507$1,277$581$430--
Worldwide Medical Devices Revenue $27,300$26,592$25,119$25,137$27,522
Worldwide Neuroscience Revenue $6,101$5,986$6,085$6,259$6,487
Worldwide Oncology Revenue $9,394$7,258$5,807$4,695$4,457
Worldwide OPSUMIT Revenue $1,161$573------
Worldwide Oral Care Revenue $1,549$1,531$1,568$1,580$1,647
Worldwide Orthopaedics Revenue $8,962$9,258$9,334$9,262$9,675
Worldwide Other / Cardiovascular / Metabolism Revenue $1,550$1,660$1,596$2,174$2,432
Worldwide Other Immunology Revenue $123$85$25$39$66
Worldwide Other Infectious Diseases Revenue $557$619$774$815$1,096
Worldwide Other Neuroscience Revenue $1,771$1,821$1,890$2,065$2,470
Worldwide Other Oncology Revenue $546$504$771$422$602
Worldwide Other Pulmonary Hypertension Revenue $154$132------
Worldwide Over the Counter Revenue $4,291$4,126$3,977$3,975$4,106
Worldwide Pharmaceutical Customer Revenue $40,225$36,256$33,464$31,430$32,313
Worldwide PREZISTA / PREZCOBIX / REZOLSTA Revenue $1,930$1,821$1,851$1,810$1,831
Worldwide PROCRIT / EPREX Revenue $999$972$1,105$1,068$1,238
Worldwide Pulmonary Hypertension Revenue $2,516$1,371------
Worldwide Remicade Revenue $5,554$6,315$6,966$6,561$6,868
Worldwide Risperdal Consta Revenue $756$805$893$970$1,190
Worldwide Simponi/Simponi Aria Revenue $2,092$1,833$1,745$1,328$1,187
Worldwide Skincare Revenue $0$0$3,897$3,531$3,758
Worldwide Specialty Revenue $1,356$1,340$1,417$1,460--
Worldwide Spine & Other Revenue $3,344$3,725$3,880$2,943--
Worldwide Stelara Revenue $4,793$4,011$3,232$2,474$2,072
Worldwide Surgery Revenue $9,872$9,559$9,296$9,217--
Worldwide Surgical Revenue $1,253$1,027------
Worldwide TRACLEER Revenue $589$403------
Worldwide Trauma Revenue $2,694$2,616$2,569$1,872--
Worldwide UPTRAVI Revenue $612$263------
Worldwide Velcade Revenue $1,135$1,114$1,224$1,333$1,618
Worldwide Vision Care Revenue $4,539$4,063$2,785$2,608--
Worldwide Womens Health Revenue $1,054$1,050$1,067$1,200$1,302
Worldwide Wound Care/Other Revenue $707$779$797$1,177$1,444
Worldwide XARELTO Revenue $2,579$2,500$2,288$1,868$1,522
Worldwide Zytiga Revenue $3,467$2,505$2,290$2,231$2,237